# Brief Escalation of Adalimumab Treatment for Prevention of Clinical Relapse in IBD

> **NCT03059849** · PHASE4 · WITHDRAWN · sponsor: **McMaster University**

## Conditions studied

- Crohn Disease
- Ulcerative Colitis

## Interventions

- **DRUG:** Adalimumab

## Key facts

- **NCT ID:** NCT03059849
- **Lead sponsor:** McMaster University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-02-01
- **Primary completion:** 2019-02-01
- **Final completion:** 2019-09-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** lack of funding
- **Last updated:** 2020-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03059849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03059849, "Brief Escalation of Adalimumab Treatment for Prevention of Clinical Relapse in IBD". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03059849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*